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SUMMARY
Viral diversity and evolution play a central role in processes such as disease emergence, vaccine
failure, drug resistance, and virulence. However, significant challenges remain to better understand
and manage these processes. Here, we discuss five of these challenges. These include improving
our ability to predict viral evolution, developing more relevant experimental evolutionary systems,
integrating viral dynamics and evolution at different scales, systematic appraisal of the virosphere,
and deepening our understanding of virus-virus interactions. Intensifying future research on these
areas should improve our ability to combat viral diseases, as well as to exploit viral diversity and
evolution for biotechnological purposes.
INTRODUCTION
Viruses are extremely abundant, genetically diverse, and fast-evolving entities. They possess
widely different replication strategies, genome organizations, and virion structures. Many viruses,
particularly RNA viruses, evolve within short, human-observable timescales (1). This helps us
not only understand previous evolutionary events, but potentially also predict their occurrence,
anticipating important processes such as virulence evolution, vaccine escape, and drug resistance.
For instance, the recent SARS-CoV-2 pandemic highlights the need to understand patterns
of viral cross-species transmission, emergence, diversification, and adaptation to a novel host.
However, evolution is an open-ended, complex, and inherently stochastic process, challenging our
ability to predict its course. Multiple challenges therefore remain. For example, it is often found
that the conclusions obtained about viral evolution in one context or timescale are no longer
correct in alternative settings, for instance when short-term evolutionary rates are extrapolated
to longer timescales. Achieving greater generality and consistency requires the collection of
more comprehensive data and the construction of more flexible and integrative models for its
interpretation. Below, we discuss specific challenges underpinning the goal of achieving higher
predictability, consistency, and comprehensiveness in the field.
Sanjuán et al. Five Challenges in Viral Evolution
ANTICIPATING VIRAL EVOLUTION
Predicting viral evolution is a long-sought goal, a particular
focus of such efforts being human strains of influenza virus,
which require constant vaccine updates (2). The advent of
high-throughput sequencing has facilitated massive genome-
wide viral sequencing in real time during the course of viral
epidemics, as already evidenced during the 2013–2014 Western
African Ebola epidemic (3) and the emergence of Zika in South
America in 2015–2016 (4). With the SARS-CoV-2 pandemics in
2020, this approach reached massive proportions, with hundreds
of thousands of full-genome sequences being released within
months (gisaid.org) (5). By linking epidemiological information
with sequence data, it has been possible to track the early spread
of new variants exhibiting enhanced transmissibility, such as
lineage B.1.1.7 emerged in the UK, anticipating their ability to
outcompete other lineages and become dominant in different
populations (6). Data collection on this scale constitutes a turning
point in the field, making it feasible to predict certain aspects of
viral evolution in the real world at a global scale.
However, major challenges still remain in this area. Although
we are currently capable of forecasting the dynamics of some viral
variants, our ability to predict the emergence of new variants of
concern is still somewhat limited. Progress in this direction will
require additional tools, including the experimental evaluation
of fitness landscapes and mutational pathways to assess the
evolutionary potential of a viral strain (7). RNA viruses are
particularly convenient systems for investigating this topic, since
they have simple genomes, can bemanipulated easily, andmutate
rapidly. For instance, the recurrent emergence of certain variants
both in laboratory evolution experiments and in nature can help
us predict the evolution of some viral features (8, 9).
Nevertheless, we are still far from reaching predictability in
other settings, particularly concerning viral transmission from
wild animals into humans, which is the main source of new,
potentially pandemic viruses. With hundreds of thousands of
wildlife viruses with zoonotic potential but just a handful of
zoonotic events, it is at present not possible to say when and
where a new virus will first infect and spread efficiently among
humans (10). However, risk factors such as local biodiversity,
ecological disturbance, viral genetic features, receptor usage, and
host tropism have been identified (11, 12). In the not-so-distant
future, we might achieve better predictability by combining
viromics, machine learning, and experimental virology tools (13–
15).
DEVELOPING MORE RELEVANT
EXPERIMENTAL EVOLUTION SYSTEMS
Controlled laboratory experiments can provide useful
information about the repeatability and predictability of
viral evolution (16). Surprisingly, non-viral systems have often
predominated in this discussion (17), despite the suitability of
viruses, considering their fast evolution and simple genomes. It
has been well-established that, under strong directional selection,
viral evolution in the laboratory often produces parallel evolution
events at the sequence level, as for instance shown in a recent
long-term HIV evolution experiment (18). This information
can be used for identifying candidate adaptive mutations, which
can be then analyzed by genetic engineering. Advances such as
deep mutational scanning and microfluidics help us generate
viral diversity more efficiently in the laboratory, and allow
experimental evolution to be carried out in a more systematic
and automated manner, accelerating adaptation and increasing
experimental repeatability (7).
By combining laboratory virus evolution with high-
throughput mutagenesis or sequencing, virologists have
characterized the distribution of mutational fitness effects with
unprecedented detail, such that the effect of nearly every possible
individual mutation can now be measured (19). However, the
question remains to what extent these experiments, which are
typically carried out in simple cell culture systems, capture
important aspects of viral evolution in nature. Certain selective
pressures, such as receptor usage, are probably well-modeled
using cell cultures. However, evolutionary experiments are
typically conducted using monolayers of tumoral cells, which
tend to exhibit aberrant innate immune responses and thus
offer an unnaturally permissive environment for viral spread.
Cultures of non-tumoral cells, as well as 3D cultures, organoids,
and explants should better reflect some selective pressures found
in vivo (20, 21). On the other hand, these systems are harder to
implement and less efficient at selecting specific viral mutations
because they achieve lower viral yields and, consequently, lower
effective population sizes. One way or another, we need to better
link experimental evolution systems with virus diversity and
evolution in nature by contrasting them with field data. Finally,
we should acknowledge that, at present, most viruses identified
in nature have not even been isolated, and thus cannot be
cultured. Despite these major limitations, experimental strategies
such as creating pseudotypes or replicons by de novo DNA or
RNA synthesis help us investigate important aspects of some
wildlife viruses in the laboratory, including receptor-dependent
cell tropism and innate immunity evasion.
INTEGRATING VIRAL DYNAMICS AND
EVOLUTION AT DIFFERENT SCALES
An important issue in the field is that viral evolution rates
inferred from phylogenetic analyses are strongly dependent on
measurement timescales, such that rates estimated from recent
isolates (e.g., seasonal outbreaks) are systematically higher than
those estimated for longer time periods [e.g., permafrost or
archival samples; (22, 23)]. This inconsistency needs to be
addressed for viral phylogenetic trees to provide more reliable
information about the time at which different groups evolved.
Similarly, to date relatively few studies have successfully linked
evolutionary processes occurring at different levels, spanning
intra-host, inter-host, and community levels. Some important
steps forward have been recently made in this direction, though,
such as identifying common evolutionary events at these different
spatiotemporal scales (24).
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A particularly challenging issue is defining and measuring
viral fitness at these different organizational levels. Whereas
at certain stages of infection or in a simplified laboratory
setting fitness is largely determined by the rate at which a
virus can infect cells (which in turn includes factors such as
receptor binding, replication and gene expression rates, etc.),
the ability to evade innate and adaptive immunity becomes
increasingly important as the infection progresses. In the process
of transmission, other factors such as the ability to be shed from
hosts and environmental stability become critical. There is a
need to better link mechanistically well-defined aspects of the
viral infection cycle (e.g., polymerase catalytic efficiency, receptor
binding affinity, capsid stability, etc.) to observable fitness at the
population level (e.g., the basic reproductive rate, R0).
CHARACTERIZING AND UNDERSTANDING
THE VIROSPHERE MORE THOROUGHLY
Our knowledge of global viral diversity in nature is still very
incomplete and biased. Classical virology has focused heavily on
viral pathogens infecting humans, livestock, and cultivars. The
metagenomics revolution has begun to reveal a much broader
picture, and suggests that we currently know <1% of the existing
viruses in nature (25). Strategies to more efficiently discover
viruses from new or underrepresented viral groups are needed.
Currently, a large fraction of sequence reads (up to 90% in some
cases) from environmental samples categorize as “dark matter,”
that is, sequences mapping to no other known biological entities
(26). Remote homology detection tools and approaches that do
not rely solely on comparative analysis of nucleic acid sequences
are needed. For instance, prediction of viral capsid structures
using artificial neural networks has recently contributed to
identifying thousands of highly divergent new DNA viruses (27).
Characterizing the virosphere clearly goes beyond sequencing.
We also need to address how different groups evolved from one
another, how viral phylogenetic trees map to different ecosystems
and hosts, why certain viral features have evolved recurrently
in certain cases (e.g., multicomponent viruses mainly found in
plants), how the ancestry of major viral groups is connected (e.g.,
whether insects served as evolutionary bridges between plant and
animal viruses), and so on. The benefits of better characterizing
and understanding the virosphere are manifold. For instance, we
will achieve a broader picture of viral cross-species transmission,
which should in turn inform viral emergence studies. We will
also better identify factors involved in the transition from
commensalism to parasitism.
IMPROVING OUR UNDERSTANDING OF
VIRUS-VIRUS INTERACTIONS
The success of a viral infection sometimes depends not only
on viral and host genotypes, but also on the presence of other
microorganisms, including viruses, as revealed for instance when
examining the viromes of flu-susceptible and flu-resistant wild
birds (28). Some virus-virus interactions can be indirect, for
instance by modifying the immune status of the host, whereas
in other cases viruses interact more directly, such as in the
case of satellite viruses. Virus-virus interactions can also involve
members of the same viral species, which can cooperate or
cheat according to the principles of social evolution (29). Well-
known instances of such interactions include the emergence of
defective viral genomes at high multiplicities of infection (30),
but also more recently discovered processes such as cooperative
immunity evasion in animal viruses and bacteriophages (31,
32). Moreover, viruses often undergo inter-host transmission
or intra-host dissemination as pools of jointly dispersing viral
particles, such as virion clusters enclosed in extracellular vesicles
or virion aggregates (33), promoting coinfection.Whereas, virus-
virus interactions typically take place when viruses share gene
products in coinfected cells, it has been found that these
interactions can also be established at the intercellular level.
For instance, some temperate bacteriophages regulate lysis at
the population level using small diffusible molecules encoded
in their genomes, a system that resembles bacterial quorum
sensing (34). Also, multicomponent viruses do not need to
coinfect individual cells with particles containing each of the
genome segments. Instead, viral products encoded by different
segments are shared at the intercellular level in a process called
distributed infection (35). The evolutionary stability of most
of these processes depends on the spatial structure of viral
infections, since this determines whether virus-virus interactions
remain local or become systemic. As such, better understanding
how viral infections progress anatomically and how this shapes
spatial population structure remains another important research
topic (36, 37).
At a broader scale, coinfections are at the origin of horizontal
gene transfer among viruses, although this process can also be
driven via gene transfer to the host and subsequent capture by
other viruses. Either way, gene exchange plays a fundamental
role in host range evolution, the virus-host arms race, and
virus-host coevolution at large. Improving our knowledge of
horizontal gene transfer in viruses is challenging for several
reasons. For most viral taxa, the number of complete and
closely related genomes is small, which affects the inference of
gene exchange events. In more thoroughly studied groups, such
as mycobacteriophages, the emerging picture is that extensive
horizontal gene transfer has produced an evolutionary network
of mosaic-like viral genome structures that is poorly described
by classical dichotomous phylogenetic trees (38). However, due
to the high substitution rates that characterize viral genomes,
homologous genes exchanged in the past often diverge beyond
the point where accurate inferences can be made. Finally, the
high proportion of open reading frames with unknown function
restricts our ability to understand the functional consequences of
genome plasticity.
CONCLUSION
The above list of challenges is far from exhaustive, yet
helps us discuss how certain active research areas might
progress in the near future. Importantly, these challenges are
clearly interconnected. For instance, improving systems for
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experimental evolution should help us build more accurate
predictions about viral evolution in nature, and better
characterizing the virosphere should help us improve our
understanding of virus-virus interactions. Some recent advances
brought by these synergies have enforced deep changes in the
virology and evolutionary biology communities, such as the way
viral species are defined or the realization that most viruses are
probably not pathogenic. Research at the interface between these
areas should be encouraged too, such as for instance combining
experimental virology and metagenomics. In the end, this should
help us make viral evolution a more predictive, comprehensive
and consistent scientific discipline.
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